Using Modeling and Simulation for Pediatric Drug Decisions
Author Information
Author(s): Barrett Jeffrey S, Mondick John T, Narayan Mahesh, Vijayakumar Kalpana, Vijayakumar Sundararajan
Primary Institution: The Children's Hospital of Philadelphia
Hypothesis
Can modeling and simulation improve pharmacotherapeutic decision-making in pediatrics?
Conclusion
The management of pediatric pharmacotherapy can be greatly enhanced via decision analytics that incorporate individualized patient data.
Supporting Evidence
- The study developed a methotrexate dashboard to visualize dosing events and predict toxicity.
- Bayesian forecasting was used to improve predictions of drug concentrations in patients.
- The dashboard integrates data from electronic medical records to provide real-time decision support.
Takeaway
This study shows that using computer models can help doctors make better decisions about how to give medicine to kids, especially when there isn't much information available.
Methodology
The study used nonlinear mixed-effect models and Bayesian forecasting algorithms to create drug-specific decision support systems based on patient data.
Limitations
The study relies on historical data and may not account for all individual patient variations.
Participant Demographics
Participants included 240 pediatric patients with a gender distribution of approximately 48% male and 52% female, aged 1 to 80 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website